15 completed, 4 unknown. 19 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 19 | Completed 15, Unknown 4 |
Follow Meningitis, Cryptococcal: new trials by email Literature Review of Meningitis, Cryptococcal trials Research Report on Meningitis, Cryptococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City Histoplasma Urine Antigen Lateral Flow Antigen test, Cryptococcal Lateral Flow Antigen test, Tuberculosis-lipoarabinomannan Lateral Flow Antigen test - Acquired Immunodeficiency Syndrome, Histoplasmosis AIDS | Not applicable | Unknown | National Institute of Respiratory Diseases, Mexico | 211 | 2023-04-01 | 2023-01-17 |
| Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis Amphotericin B Colloidal Dispersion, flucytosine, fluconazole - Cryptococcal Meningitis | Not applicable | Unknown | Peking Union Medical College Hospital | 30 | 2022-08-22 | 2022-07-22 |
| Driving Reduced AIDS-associated Meningo-encephalitis Mortality DREAMM - AIDS-Related Opportunistic Infections, Meningo-encephalitis | Not applicable | Completed | St George's, University of London | 495 | 2016-04-23 | 2022-05-04 |
| Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS Fluconazole, Antiretroviral therapy - Cryptococcal Meningitis | Not applicable | Unknown | ANRS, Emerging Infectious Diseases | 186 | 2015-07-01 | 2018-03-15 |
| Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis Liposomal amphotericin B, Amphotericin B-deoxycholate - Cryptococcal Meningitis | Not applicable | Unknown | TTY Biopharm | 84 | 2011-02-01 | 2014-05-12 |
| Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa Fluconazole, Fixed dose - Stavudine, lamivudine and Nevirapine, Fixed dose - Stavudine, Lamivudine, Nevirapine - Cryptococcal Meningitis, HIV Infections | Not applicable | Completed | University of Zimbabwe | 54 | 2006-10-01 | 2016-07-18 |
| An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis Itraconazole, Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 400 | 2021-11-02 | |
| Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome Amphotericin B, Lipid-based, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Liposome | 2005-06-24 | ||
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | 2011-03-14 | |
| Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis. Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 64 | 2005-06-24 | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 | ||
| A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS Fluconazole - Meningitis, Cryptococcal, HIV Infections | Not applicable | Completed | Pfizer | 2005-06-24 |
Acquired Immunodeficiency Syndrome (14) · HIV Infections (14) · Meningitis (14) · Cryptococcosis (13) · AIDS-Related Opportunistic Infections (12) · Brain Diseases (1) · Latent Tuberculosis (1) · Meningitis, Bacterial (1) · Toxoplasmosis, Cerebral (1) · Tuberculosis, Meningeal (1)
Bacterial Infections and Mycoses (19) · Central Nervous System Diseases (19) · Central Nervous System Fungal Infections (19) · Central Nervous System Infections (19) · Infections (19) · Meningitis, Fungal (19) · Mycoses (19) · Nervous System Diseases (19) · Neuroinflammatory Diseases (19) · Blood-Borne Infections (16) · Communicable Diseases (16) · Immune System Diseases (16) · Immunologic Deficiency Syndromes (16) · Lentivirus Infections (16) · RNA Virus Infections (16)
Fluconazole (15) · Amphotericin B (9) · Flucytosine (6) · Antiretroviral Therapy, Highly Active (1) · Injections (1) · Itraconazole (1) · Lamivudine (1) · Nevirapine (1) · Stavudine (1) · amphotericin B, deoxycholate drug combination (1) · liposomal amphotericin B (1)
Pfizer (10) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · ANRS, Emerging Infectious Diseases (1) · Liposome (1) · National Institute of Respiratory Diseases, Mexico (1) · Peking Union Medical College Hospital (1) · St George's, University of London (1) · TTY Biopharm (1) · University of Zimbabwe (1)
United States (13) · Canada (3) · Cameroon (2) · China (1) · Malawi (1) · Mexico (1) · Taiwan (1) · Tanzania (1) · Zimbabwe (1)
Angela Loyse, MD (1) · Armstrong D (1) · Azure T Makadzange, MD, DPhil (1) · Charles Kouanfack, MD, PhD (1) · Chiratidzo E Ndhlovu, MBChB, FRCP (1) · Elvis Temfack, MD, MSc (1) · James Hakim, MBChB, FRCP (1) · Olivier Lortholary, MD, PhD (1) · Saag M (1) · Taisheng Li, PhD (1) · Thomas Harrison, MD (1) · Yee-chun Chen, MD (1) · van der Horst C (1)